Cargando…
miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells
OBJECTIVE: The aim of the recent study was to investigate the effects of miR-205 on reversing Doxorubicin (DOX) resistance, as chemotherapeutic agents through up-regulation of PTEN in human liver cancer HepG2 cells. MATERIALS AND METHODS: In this experimental study, the drug resistance in liver canc...
Autores principales: | Li, Mei, Li, Zhubin, Song, Juanrong, Li, Xu, Zhai, Pengtao, Mu, Xudong, Qiu, Fakai, Yao, Le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035231/ https://www.ncbi.nlm.nih.gov/pubmed/35451580 http://dx.doi.org/10.22074/cellj.2022.7231 |
Ejemplares similares
-
MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
por: Zheng, Shun-Zhen, et al.
Publicado: (2019) -
Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
por: Korga, Agnieszka, et al.
Publicado: (2019) -
miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
por: Zou, Zhenyou, et al.
Publicado: (2017) -
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
por: Yu, Ge, et al.
Publicado: (2016) -
Melittin Restores PTEN Expression by Down-Regulating HDAC2 in Human Hepatocelluar Carcinoma HepG2 Cells
por: Zhang, Hui, et al.
Publicado: (2014)